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Abstract
Background: Air pollutants have been linked to type 2 diabetes (T2D), hypothesized to act through inflammatory
pathways and may induce interleukin-6 gene (IL6) in the airway epithelium. The cytokine interleukin-6 may impact
on glucose homeostasis. Recent meta-analyses showed the common polymorphisms, IL6 -572G > C and IL6 -174G > C
to be associated with T2D risk. These IL6 variants also influence circulatory interleukin-6 levels. We hypothesize that
these common functional variants may modify the association between air pollutants and T2D.
Methods: We cross-sectionally studied 4410 first follow-up participants of the Swiss Cohort Study on Air Pollution and
Lung and Heart Diseases (SAPALDIA), aged 29 to 73 years who had complete data on genotypes, diabetes status and
covariates. We defined diabetes as self-reported physician-diagnosed, or use of diabetes medication or non-fasting
glucose >11.1 mmol/L or HbA1c > 0.065. Air pollution exposure was 10-year mean particulate matter <10 μm in diameter
(PM10) assigned to participants’ residences using a combination of dispersion modelling, annual trends at monitoring
stations and residential history. We derived interaction terms between PM10 and genotypes, and applied mixed logistic
models to explore genetic interactions by IL6 polymorphisms on the odds of diabetes.
Results: There were 252 diabetes cases. Respective minor allele frequencies of IL6 -572G > C and IL6 -174G > C
were 7 and 39 %. Mean exposure to PM10 was 22 μg/m3. Both variants were not associated with diabetes in
our study. We observed a significant positive association between PM10 and diabetes among homozygous
carriers of the pro-inflammatory major G-allele of IL6 -572G > C [Odds ratio: 1.53; 95 % confidence interval
(1.22, 1.92); Pinteraction (additive) = 0.003 and Pinteraction (recessive) = 0.006]. Carriers of the major G-allele of IL6 -174G > C also
had significantly increased odds of diabetes, but interactions were statistically non-significant.
Conclusions: Our results on the interaction of PM10 with functionally well described polymorphisms in an important
pro-inflammatory candidate gene are consistent with the hypothesis that air pollutants impact on T2D through
inflammatory pathways. Our findings, if confirmed, are of high public health relevance considering the ubiquity of the
major G allele, which puts a substantial proportion of the population at risk for the development of diabetes as a result
of long-term exposure to air pollution.
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Background
Evidence suggests a positive association between ambi-
ent air pollution and risk of type 2 diabetes (T2D) [1–3].
This association is hypothesized to be mediated through
inflammatory mechanisms. Experimental evidence [4, 5]
suggests subclinical systemic inflammation occurring at
several sites including adipose tissue, liver, skeletal mus-
cles and the autonomic nervous system, with resultant
insulin resistance, the hallmark of T2D. On the popula-
tion level, acute and long-term exposure to ambient air
pollution has been linked to raised markers of inflamma-
tion including circulating C-reactive proteins (CRP) [6, 7]
IL-6, [8] fibrinogen [9, 10] vascular and intracellular adhe-
sion molecules [11]. Indeed, air pollution is thought to ac-
celerate pro-thrombotic state following lung inflammation
through an IL-6 dependent pathway [12, 13]. Exposure to
industrial particulate matter has been shown to induce IL-
6 genes in human airway epithelial cells [14]. Likewise,
exposure of mice to particulate matter induced the
expression of genes involved in inflammation, lipid metab-
olism and atherosclerosis [8].
IL-6 in itself may be related to the development of
type 2 diabetes [15]. Elevated levels of IL-6 were associ-
ated with higher incidence of type 2 diabetes [16, 17],
and animal studies also showed IL-6 to inhibit insulin
secretion from islet cells following glucose stimulation
[18]. Other in vitro studies also showed negative impacts
of IL-6 on insulin sensitivity through reduced insulin re-
ceptor expression [19] and adiponectin gene expression
[20] in adipocytes. Among T2D patients, IL-6 was asso-
ciated with whole-body insulin resistance and hypergly-
cemia [21]. Raised IL-6 levels were also associated with
hyperinsulinemia in patients without T2D [22].
IL6 gene plays an important role in the regulation of sys-
temic inflammatory pathways. Some common single nu-
cleotide polymorphisms (SNPs), including IL6 -572G >C
and IL6 -174G > C have been shown to influence the levels
of circulatory IL-6 [23, 24], as well as circulating CRP [25].
In these studies, the major G alleles of both variants were
identified as the pro-inflammatory alleles. Recent meta-
analyses of 11,681 individuals of Asian and European des-
cent showed the G allele of IL6 -572G >C to be associated
with increased risk of T2D [26] whereas another study of
22,626 individuals of European descent showed the C allele
of IL6 -174G >C to be associated with decreased risk of
T2D [27].
Studying gene-environment interactions helps to better
understand aetiologic mechanisms and causality of
exogenous factors, in this case, air pollution, and to iden-
tify population at increased risk of adverse health effects
of environmental exposures. We hypothesize, based on
the above evidence, that the common functional SNPs,
IL6 -572G > C and IL6 -174G > C, may modify the existing
association between air pollutants and diabetes [28].
Methods
Study population
We studied participants of the Swiss Cohort Study on Air
Pollution and Lung and Heart Diseases in Adults (SAPAL-
DIA). This study has been described elsewhere in detail
[29]. Briefly, it consists of a population-based sample of
9651 adults, aged 18–60 when they were recruited at base-
line (1990/1991) from eight communities reflecting the di-
verse geographic and climatic features of Switzerland.
Participants underwent health interviews and physical ex-
aminations. At first follow-up (2001/2002) which add-
itionally included blood marker and genetic assays, 8047
participants completed at least the screening question-
naire [30]. 6212 participants at first follow-up, consenting
to genetic assays were genotyped for IL6 -572G > C and
IL6 -174G > C in those studies. For the present analysis,
we studied 4410 follow-up participants, aged 29–73 years,
with complete data on diabetes status, selected covariates,
and population stratification data from genome-wide asso-
ciation studies. The algorithm for participant selection is
shown on Fig. 1.
Participants provided informed consent for participa-
tion in the health interviews, physical examinations,
blood marker and genetic assays. Ethical clearance for
the SAPALDIA study was obtained from the Swiss
Academy of Medical Sciences, the National Ethics Com-
mittee for Clinical research (UREK, Project Approval
Number 123/00) and the Ethics Committees of the eight
participating communities including Basel, Wald, Davos,
Lugano, Montana, Payerne, Aarau and Geneva.
Identification of diabetes cases
Participants were identified as having diabetes if they 1)
reported physician diagnosed diabetes or 2) use of
diabetes medication in the past month or 3) had non-
fasting blood glucose >11.1 mmol/L or 4) HbA1c >0.065.
Non-fasting blood glucose was measured in all partici-
pants whereas HbA1c was only measured if non-fasting
glucose >6.1 mmol/L [28]. The lack of data on diabetes
status at baseline precluded the study of incident diabetes.
Also, we could not exclude type 1 diabetes (T1D) and
have assumed the majority of these cases to be T2D con-
sidering that on the average, >90 % of adult diabetes are
T2D [31].
Individual assignment of air pollution exposure
We considered 10-year means of PM10 (particulate mat-
ter <10um in diameter) as our pollutant exposure meas-
ure of interest. In our previous studies on diabetes [2]
and metabolic syndrome [32], associations with nitrogen
dioxide (NO2) disappeared in two-pollutant models that
included NO2 and PM10, whereas those of PM10
remained unchanged. Therefore we did not consider
NO2 in this study. Estimates of PM10 exposure were
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assigned to participants’ residential addresses using dis-
persion models for the years 1990 and 2000 (respective
years before baseline and follow-up) [33]. This model
incorporated data from meteorology, topography and
several emission inventories including industrial, agricul-
tural, heavy equipment and traffic at a resolution of
200 × 200 m [34]. Annual PM10 levels measured at fixed
monitoring stations across Switzerland and participants’
residential histories were further used to derive estimates
of mean PM10 exposure at participants’ residential ad-
dresses over the 10-year period preceding the first
follow-up health examination [28].
Genotyping of candidate SNPs, IL6 -572G > C and
IL6 -174G > C.
Genomic DNA was extracted from ethylenediamine-
tetraacetic acid (EDTA)-buffered whole blood using
PUREGENE DNA Purification Kit (GENTRA Systems,
Minneapolis, USA) [30]. Genotyping for these polymor-
phisms was done using 5’-nuclease fluorescent polymer-
ase chain reaction (Taqman) assay (Applera Europe,
Rotkreuz, Switzerland). Detection of end-points was done
using a 7000 ABI System detection device (ABI, Rotkreuz,
Switzerland) [35]. Genotyping call rate was >97.5 %. A
random selection of 638 samples (10 %) was genotyped
twice for quality control and repeated genotypes were
100 % concordant (R2 = 1; P < 0.001). Subsamples of 3015
and 1612 SAPALDIA participants had whole genome
genotyping using the Illumina HumanOmniExomeEx-
press BeadChip and Illumina 610 K quad BeadChip (Illu-
mina, San Diego, CA, USA) respectively. In this combined
SAPALDIA subsample which are predominantly of
Caucasian ancestry, we derived ten population stratifica-
tion components using multidimensional scaling analysis
(Plink v1.07 [36]) on 72,122 SNPs with MAF > 1 % and
genotyping call rate >97 %, present on both genotyping
arrays.
Potential confounders
We considered the following characteristics, based on
our previous publication on air pollution and diabetes
[28], as potential confounders: age (years; continuous),
sex, years of formal education (≤9; >9), neighbourhood
socio-economic index developed from a principal com-
ponent analysis including occupation and educational
level of household head, median rent and number of
persons living in a household, expressed as a percentage
[37]. We also considered smoking history (current,
former and never smoker; and smoked pack-years com-
puted by multiplying number of cigarette packs per year
and number of smoking years), exposure to passive
smoke (yes/no), occupational exposure to vapours gases,
dusts and fumes (yes/no) daily consumption of at least
one portion of fruits and vegetables (never; ≤3 days/
week; >3 days/week respectively). We also considered al-
cohol consumption (including beers, wines, spirits and
liquors: never; ≤1glass/day; >1glass/day); hours per week
of vigorous physical activity defined as taking part in ac-
tivities that make one sweat or out of breath (<0.5; ≥0.5),
body mass index (BMI; kg/m2, continuous) and genome-
wide population stratification components.
Statistical analyses
We assessed linkage disequilibrium between IL6 -572G >C
and IL6 -174G >C and tested both candidate SNPs for
Hardy-Weinberg equilibrium (HWE) among the geno-
typed participants regardless of inclusion in the study. We
computed an IL6 genetic risk score (IRS) by summing up
the risk alleles (number of G alleles coded as 0, 1 and 2)
across both SNPs. We summarized the characteristics of
4410 included participants based on their genotype and
also by inclusion and exclusion status. We applied a mixed
Fig. 1 Algorithm for participant inclusion in the present study
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logistic regression model, with a random intercept by study
area to explore the associations of diabetes with both SNPs,
IRS and with PM10. We generated interaction terms be-
tween PM10 and candidate SNPs (including IRS) and
assessed their associations with prevalent diabetes. Inter-
action analyses with candidate SNPs involved additive, re-
cessive and co-dominant models. Stratifying by genotype,
we assessed the associations between PM10 and diabetes,
to identify genotype-specific associations. We also stratified
by groups of IRS indicating increased inflammatory risk.
Since this study included 46 % of baseline participants
which differed in several sociodemographic characteristics
(Additional file 1: Table S1), we assessed the effect of po-
tential participant selection bias on our results using in-
verse probability weighting by applying the inverse of the
probability of participating in present study derived at
baseline (using variables that significantly predicted partici-
pation in the present study), to the primary model in this
study. All analyses were performed using a primary
model which included, after stepwise selection, partici-
pants’ age, sex, educational attainment, neighbourhood
socio-economic index, smoking status, smoked pack-
years, exposure to passive smoke, occupational expos-
ure to vapours, gases, dusts and fumes, consumption of
fruits and vegetables, vigorous physical activity, BMI
and genome-wide population stratification components
and applying a random intercept by study area.
We performed several sensitivity analyses. We defined
diabetes based on each of the diagnostic criteria (exclud-
ing the cases identified only by alternative criteria). We
repeated the interaction analyses using mixed logistic re-
gression models with random slopes by study area to ex-
plore if study area influenced any of the observed
interactions. All statistical analyses were performed with
STATA software, version 14 (Stata Corporation, Texas).
Results
There were 252 diabetes cases in this study. Mean ex-
posure to PM10 was 22.6ug/m
3 and mean IRS was 3 risk
alleles. IL6 -572G > C and IL6 -174G > C were not in
linkage disequilibrium (R2 = 0.02; D’ = 1.0). The results
of the HWE test for IL6 -572G > C and IL6 -174G > C,
which have respective minor allele frequency of 7 and
39 % in the SAPALDIA population are shown in Table 1.
IL6 -174G > C was in HWE in both cases and controls
whereas IL6 -572G > C only reached HWE among the
diabetes cases (P = 0.636) and not among those without
diabetes (P = 0.006). The overall HWE test for IL6
-174G >C and IL6 -572G >C was 0.408 and 0.006
respectively (Table 1). In the European study of ~6000 par-
ticipants reporting an association between IL6 -572G >C
and T2D, this functional SNP (having MAF= 5 %) was also
not in HWE [38]. Since only 30 participants carry the minor
CC genotype of IL6 -572G >C, we present the results for
this SNP as GG vs. GC +CC, which yields better statistical
power.
Compared to the carriers of the major GG genotype,
carriers of the GC + CC genotype of IL6-572G > C had
higher body mass index and PM10 exposure whereas car-
riers of CC genotype of IL6 -174G > C smoked more,
consumed more alcohol and had lower exposure to
PM10 and there was a significant difference in genotype
distribution across areas (Table 2). There was no signifi-
cant difference in diabetes prevalence across genotypes
for both polymorphisms (Table 2). Additional file 1:
Table S1 shows the differences in these characteristics
between the included and excluded participants. There
were significant differences in most of the participants’
characteristics including diabetes prevalence and PM10
exposure, but the prevalence of these characteristics
were generally higher among the included participants
compared to the excluded ones (Additional file 1: Table
S1). The IL6 -572G > C and IL6 -174G > C genotypes,
and IRS were similarly distributed between both groups
(Additional file 1: Table S1).
The positive association between air pollutants and
diabetes, which we previously observed in our previous
study of 6392 participants at this follow-up study [28],
persisted in the present sample. The adjusted odds of
diabetes increased by 47 % (95 % CI: 1.21, 1.78) per
Table 1 Distribution of IL6 -572 G > C and IL6 -174 G > C
genotypes and alleles by diabetes status
Genotype Diabetes No diabetes
N = 286 N = 5554
IL6 -572 G > C*
Genotype
GG 248 (86.7) 4896 (88.2)
GC 36 (12.6) 623 (11.2)
CC 2 (0.7) 35 (0.6)
Allele
G 532 (93) 10415 (93.7)
C 40 (7) 693 (6.3)
IL6 -174 G > C**
Genotype
GG 111 (39) 2081 (37)
GC 135 (47) 2614 (47)
CC 40 (14) 865 (16)
Allele
G 357 (62) 6776 (61)
C 215 (38) 4344 (39)
Data are presented as absolute numbers (N) and relative numbers (%)
in parentheses
*P-value for Hardy-Weinberg Equilibrium (HWE) test in diabetes cases = 0.585;
no diabetes = 0.006; overall = 0.006. P-value for Fisher’s exact test = 0.664
**P-value for Hardy-Weinberg Equilibrium test in diabetes cases = 0.918; no
diabetes = 0.352; overall = 0.408. P-value of Chi-square test = 0.762
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10ug/m3 of exposure to PM10. We did not observe any
significant association between the candidate IL6 SNPs
and diabetes, across three genetic models. We also did
not observe significant associations between IRS and
diabetes in our sample (Additional file 1: Table S2).
Stratified by genotypes, the association between PM10
and diabetes was most pronounced among carriers of
the major GG pro-inflammatory alleles for both poly-
morphisms (Fig. 2). We observed significant interactions
between PM10 and IL6 -572G > C in the additive and re-
cessive models which became more significant in the
models accounting for potential selection bias by IPW
and remained significant following Bonferroni correction
at P = 0.01 (0.05/5) (Table 3). We did not observe any
statistically significant interactions with IL6 -174G > C
across genetic models and adjustment for potential se-
lection bias by IPW (Table 3). We observed a positive
trend in the association between PM10 and diabetes across
levels of IRS (Fig. 2). Carriers of four pro-inflammatory G
alleles had the highest odds of diabetes per 10ug/m3
increase in exposure to PM10 (Pinteraction = 0.10) (Fig. 2).
Compared to carriers of two pro-inflammatory G alleles,
Table 2 Characteristics of participants by IL6 -572 G > C and IL6 -174 G > C genotypes
IL6 -572 G > C IL6 -174 G > C
GG (N = 3891) GC + CC (N = 519) P (Chi2) GG (N = 1618) GC (N = 2110) CC (N = 682) P (Chi2)
Proportion (%)
Females 48.4 49.1 0.768 48.3 48.1 50.6 0.509
Education ≥9 years 94.9 93.2 0.107 94.4 94.9 95.0 0.721
Never-smokers 44.3 45.6 0.490 42.4 44.8 48.1 0.036
Passive smoke exposure 46.4 46.6 0.927 48.6 45.4 44.4 0.078
Occupational VGDF exposure 42.8 42.4 0.845 43.9 42.6 40.9 0.398
Alcohol intake ≤1glass/day 91.0 91.4 0.620 89.8 91.2 93.0 0.050
Alcohol intake >1glass/day 9.0 9.6 10.2 8.8 7.0
Portion of raw vegetables ≤3 days/week 18.2 20.8 0.150 17.4 19.1 19.4 0.351
Portion of raw vegetables >3 days/week 81.8 79.2 82.6 80.9 80.6
Portion of fruits ≤3 days/week 35.8 35.6 0.923 35.0 36.2 36.7 0.657
Portion of fruits >3 days/week 64.2 64.4 65.0 63.8 63.3
Portion of citrus fruits ≤3 days/week 64.2 64.0 0.909 64.2 63.9 64.8 0.917
Portion of citrus fruits >3 days/week 35.8 36.0 35.8 36.1 35.2
Vigorous physical activity <0.5 h/week 35.5 37.2 0.449 37.3 34.6 34.2 0.082
Vigorous physical activity ≥0.5 h/week 64.5 62.8 62.1 65.4 65.8
Diabetes cases 5.5 6.7 0.260 6.2 5.5 4.8 0.430
Areas: Basel 11.5 12.9 0.062 10.5 11.6 14.8 <0.001
Wald 19.1 19.1 19.0 18.6 20.8
Davos 7.7 6.9 7.5 7.9 7.0
Lugano 12.6 14.6 15.0 12.6 8.4
Montana 11.1 6.9 9.2 11.2 12.0
Payerne 13.1 12.7 13.3 12.1 15.2
Aarau 16.6 19.3 16.9 17.6 14.4
Geneva 8.4 7.5 8.6 8.4 7.3
Means (SD) T-test ANOVA
Age (years) 51.8 (11) 51.3 (11) 0.269 51.8 (11) 51.8 (11) 51.5 (11) 0.732
BMI (kg/m2) 25.8 (4.3) 26.3 (4.3) 0.025 26.0 (4.3) 25.8 (4.3) 25.9 (4.3) 0.152
Neighborhood SEI 63.7 (10) 63.8 (10) 0.827 63.5 (10) 63.9 (10) 63.8 (9) 0.455
10-year mean PM10 (μg/m3) 21.8 (7.3) 22.8 (7.2) 0.005 22.3 (7.4) 21.9 (7.3) 21.5 (6.9) 0.030
Pack-years of smokinga 0 (14) 0.1 (16) 0.296 0.3 (16) 0 (16) 0 (14) 0.524
VGDF: vapours, gases, dusts and fumes; SD: standard deviation; BMI: body mass index; SEI: socio-economic index; PM10: particulate matter <10 μm in diameter.
avalues represent median (interquartile range) and P-values represent significance level of median test
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Fig. 2 Interaction between PM10 and IL6 polymorphisms on odds of diabetes. Odds ratio values represent percentage increase of odds of diabetes per
10 μg/m3 increase in PM10 exposure adjusted for potential selection bias. PM10: particulate matter <10 μm in diameter. All associations are adjusted for
body mass index, age, sex, socio-economic status, smoking habits, consumption of alcohol, fruits and vegetables, physical activity and genome-wide
population stratification. Study area was treated as a random effect in all models
Table 3 Associations and interactions between PM10 and candidate SNPs on odds of diabetes, applying inverse probability
weighting (IPW) to account for potential selection bias
Genotype Genotype-specific PM10 and diabetes
association OR (95 % CI)
P-value* P-value of interaction** P-value of interaction*** P-value of interaction****
IL6 -572G > C
Adjusted model without IPW
GG 1.53 (1.22, 1.92) <0.001 0.031 n.d. 0.058
GC + CC 0.87 (0.51, 1.49) 0.618
Adjusted model applying IPW
GG 1.53 (1.23, 1.91) <0.001 0.003 n.d. 0.006
GC + CC 0.74 (0.46, 1.20) 0.225
IL6 -174G > C
Adjusted model without IPW
GG 1.49 (1.09, 2.04) 0.012 0.763 0.966 0.645
GC 1.35 (1.01, 1.80) 0.046
CC 1.43 (0.80, 2.54) 0.226
Adjusted model applying IPW
GG 1.44 (1.07, 1.93) 0.016 0.847 0.955 0.749
GC 1.34 (1.01, 1.78) 0.044
CC 1.41 (0.76, 2.61) 0.226
Adjusted models include age, sex, educational attainment, neighborhood-level socio-economic status, smoking status, pack-years of smoking, exposure to passive
smoke and occupational dusts and fumes, dietary fibre intake, alcohol consumption, physical activity, body mass index (BMI), PM10. Study area was treated as random
effects in all models. OR: odds ratio; CI: confidence intervals; OR values represent percent increase in odds of diabetes per 10 μg/m3 increase in PM10 exposure. PM10:
particulate matter <10 μm in diameter.* P-value of genotype specific association between PM10 and diabetes.
** additive model (per G allele); ***dominant model (GG +
GC vs. CC); ****recessive model (GG vs. GC + CC); n.d.: not done due to the few number of CC allele carriers
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carriers of four risk alleles had 60 % (95 % CI: −15 %,
197 %) higher odds of diabetes per 10ug/m3 increase in
exposure to PM10. These interactions were largely stable
to confounder adjustments.
Sensitivity analyses showed very similar results. Defining
diabetes according to each of the classification criteria
showed very similar results with significant interactions in
the additive and recessive genetic models (Table 4). Odds
of diabetes identified through blood tests among GG
genotype carriers remained positive but less significant
(Table 4). Applying a logistic regression model with ran-
dom slopes by study area also did not change estimates of
the interaction between PM10 and the candidate SNPs on
prevalent diabetes, but changed the estimated association
between PM10 and diabetes among the pro-inflammatory
GG genotype carriers (Table 4). In a sub-sample of 2825
non-asthmatic participants who were genotyped using the
Illumina Human Omni Exome Express Bead Chip, where
IL6 -572G > C was in HWE (Pearson’s correlation R2
between both SNPs =1), associations persisted among
pro-inflammatory GG carriers [OR: 1.64 (1.24, 2.16)] and
interactions persisted in the models accounting for poten-
tial selection bias (P(additive) =0.053; P(recessive)= 0.048).
Discussion
We found a modifying effect of IL6 -572G > C poly-
morphism on the association between air pollutants and
diabetes, where carriers of the pro-inflammatory GG
genotype were most susceptible. These associations were
highly stable to confounder adjustments and remained
robust across several sensitivity analyses. The lack of
interaction with IL6 -174G > C is supported by the fact
that both SNPs are not in linkage disequilibrium. Com-
bining both SNPs into an IRS showed increased associ-
ation among participants at high genetic risk of
inflammation.
The lack of association between PM10 and DM among
the GG genotype carriers in the fixed effect model could
be attributed to variation of PM10 constituents across
different areas (Pearson’s R for PM10 crustal components
across four SAPALDIA areas = 0.34) [39]. Due to the fact
that the likelihood-ratio tests for interactions between
PM10 and study area (also between SNP and study area)
were non-significant (P > 0.2), and that the goal of
SAPALDIA air pollution studies is to capture the be-
tween area differences in health effects which cannot be
explained by the fixed factors in the models, we per-
formed the main analyses using area as a random covari-
ate. In addition, applying the fixed effects model did not
change our estimates of interaction between IL6 poly-
morphisms and PM10 which is our main interest in this
study. The reduced significance of interactions among
those reporting the use of diabetes medication is most
likely to be due to under-reporting of medication use.
The absence of any significant association between the
IL6 polymorphisms and diabetes in our sample may be
due to our inability to differentiate T1D from T2D, or
the relatively small number of cases compared to other
studies [26]. Thus, our observation of a significant inter-
action is surprising given the limited number of cases in
our study.
To our knowledge, this is the first evidence on gene-
air pollution interaction in adult diabetes. Until now,
gene-air pollution interaction studies focused on respira-
tory and cardiovascular outcomes, exploring diverse
candidate genes or polymorphisms, pollutants and out-
comes [40–42]. Many of the interacting genes including
IL6, regulate systemic oxidative stress and inflammatory
pathways [41, 43]. IL6 is one of the genes involved in
systemic inflammation by regulating or inducing the
production of inflammatory cytokines such as IL-6 and
CRP. In-vitro studies also show that exposure to particu-
late matter induces IL6 and CRP gene expression in epi-
thelial and macrophage cell lines [14, 44, 45]. In
addition, polymorphisms on IL6 have been shown to
interact with acute exposure to carbon monoxide and
nitrogen dioxide, in eliciting plasma IL-6 response [43].
Our results support the hypothesis that exposure to
air pollution may contribute to diabetes aetiology
through inflammatory pathways. Since we have analysed
two C/G polymorphisms located in the promoter region
of IL6 in our study, a potential mechanism of action
could be related to changes in DNA methylation at these
sites, affecting IL6 gene expression. Air pollution expos-
ure was positively associated with methylation of IL6 in
elderly men [46]. Hypomethylation of IL6 was associated
with raised levels of serum IL-6 in patients with rheuma-
toid arthritis [47], and with body weight among diabetes
patients [48]. In contrast, increased methylation of IL6
was associated with risk of obesity [49] and body weight
among patients without diabetes [48]. Furthermore there
is suggestive evidence on a potential link between epi-
genetic changes at inflammatory genes (including IL6)
and diabetes [50, 51]. While the evidence supports a role
of IL6 methylation with regard to both, air pollution and
diabetes, the relevance of hyper- versus hypomethylation
and the association with the IL6 SNPs studied here
needs further clarification.
Our study has major strengths. It provides first evi-
dence to our knowledge on gene-air pollution interac-
tions on diabetes risk. It derives from the large database
of the population-based SAPALDIA cohort, with well
characterized phenotypes, genotypes and lifestyle charac-
teristics. Our air pollution estimates were assigned to
participants’ residences and derived from validated
models which have been applied to other studies. [33]
By taking into account residential histories of partici-
pants, we could compute individual estimates of long-
Eze et al. Environmental Health  (2016) 15:39 Page 7 of 11
term exposure to air pollution, which is a crucial in under-
standing disease development and progression attributable
to air pollution. We minimized outcome misclassification
by identifying undiagnosed diabetes cases through add-
itional blood tests.
Our study also has limitations. It has a cross-sectional
design hence we cannot infer causality of observed asso-
ciations. We tried to improve this by estimating air
pollution exposure in the ten years prior to the survey
where diabetes was assessed. In addition, an exploratory
Table 4 Other Sensitivity Analyses
Sensitivity analysis Genotype Adjusted OR (95 % CI) P-value* P-value** P-value*** P-value****
Diabetes defined as self-reported physician
diagnosis and medication use
[N(diabetes) = 196]
IL6 -572G > C
GG 1.41 (1.11, 1.79) 0.005 0.001 n.d. 0.004
GC + CC 0.63 (0.38, 1.04) 0.070
IL6 -174G > C
GG 1.23 (0.88, 1.71) 0.222 0.931 0.797 0.794
GC 1.33 (0.98, 1.81) 0.065
CC 1.17 (0.58, 2.35) 0.669
Diabetes defined as self-reported physician
diagnosis only [N(diabetes) =193]
IL6 -572G > C
GG 1.43 (1.13, 1.83) 0.003 0.008 n.d. 0.003
GC + CC 0.63 (0.38, 1.04) 0.072
IL6 -174G > C
GG 1.23 (0.88, 1.71) 0.226 0.881 0.749 0.694
GC 1.38 (1.01, 1.88) 0.041
CC 1.16 (0.57, 2.33) 0.680
Diabetes defined as self-reported use of
diabetes medication only [N(diabetes) =125]
IL6 -572G > C
GG 1.25 (0.95, 1.66) 0.113 0.008 n.d. 0.031
GC + CC 0.49 (0.22, 1.10) 0.085
IL6 -174G > C
GG 1.10 (0.72, 1.66) 0.666 0.954 0.600 0.803
GC 1.24 (0.86, 1.78) 0.246
CC 0.90 (0.36, 2.28) 0.829
Diabetes cases identified from blood
tests only [N (diabetes) = 184]
IL6 -572G > C
GG 1.65 (1.27, 2.13) <0.001 0.002 n.d. 0.006
GC + CC 0.70 (0.39, 1.25) 0.223
IL6 -174G > C
GG 1.46 (1.04, 2.06) 0.030 0.738 0.553 0.962
GC 1.41 (1.00, 1.99) 0.052
CC 1.83 (0.86, 3.90) 0.118
Model applying random slopes for
study areas [N(diabetes) = 252]
IL6 -572G > C
GG 0.92 (0.44, 1.92) 0.819 0.004 n.d. 0.008
GC + CC 0.44 (0.19, 1.05) 0.065
IL6 -174G > C
GG 0.86 (0.41, 1.83) 0.704 0.814 0.928 0.687
GC 0.78 (0.36, 1.70) 0.540
CC 0.85 (0.33, 2.20) 0.735
Adjusted models include age, sex, educational attainment, neighborhood-level socio-economic status, smoking status, pack-years of smoking, exposure to passive
smoke and occupational dusts and fumes, dietary fibre intake, alcohol consumption, physical activity, body mass index (BMI), PM10. Study area was treated as
random effects in all models except the model with random slopes for study area.OR: odds ratio; CI: confidence intervals; OR values represent percent increase in
odds of diabetes per 10 μg/m3 increase in PM10 exposure. PM10: particulate matter <10 μm in diameter; n.d: not done due to very low sample size for CCgenotype.
*P-value of genotype specific association between air pollutant and diabetes. **additive model (per C allele); ***dominant model (GG + GC vs. CC); ****recessive model
(GC + CC vs.GG)
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analysis excluding 17 diabetes cases who reported to have
started using diabetes medication before 1991 gave very
similar results. We could not differentiate T1D from T2D
cases and therefore have misclassified a few cases (on the
average <10 % as T2D instead of T1D). [31].
One of our functional SNPs of interest, IL6 -572G > C,
was not in HWE (Table 1). SNPs may deviate from
HWE due to genotyping error, population stratification
or population selection [52, 53]. Therefore, we assessed
quality control by genotyping a subsample of our partici-
pants using an alternative genotyping array. There was
no indication of genotyping errors since both SNPs had
a perfect correlation between the two genotyping
rounds. Also, we adjusted for population stratification in
our study population using genome-wide principal
components. It has been shown that SNPs may still devi-
ate from HWE despite controlling for the afore-
mentioned reasons [53]. It is also important to note that
IL6 -572G > C was not in HWE in a study linking it to
T2D in Europeans [38] and the minor alleles were simi-
larly distributed between the reference study (MAF =
5 %) and our study (MAF = 7 %). Furthermore, the geno-
type frequencies were also similarly distributed [Diabetes
cases- GG: 90.6 %, GC: 9 %, CC: 0.4 %; No diabetes - GG:
86.7 %, GC: 12.6 %, CC: 0.7 % vs. Table 1). We additionally
assessed public databases to identify any potential interfer-
ence on our PCR probe by nearby SNPs but found no evi-
dence for such. We did not measure plasma IL-6
concentrations in our participants due to lack of funds,
precluding our assessment of association between candi-
date SNPs and serum IL-6 levels, but there was a positive
correlation between both SNPs and mean high-sensitivity
C-reactive proteins (hs-CRP) measured at this first follow-
up (IL6 -572G > C-CC: 1.28 g/l, GC: 1.45 g/l, GG: 1.58 g/l
and IL6 -174G >C-CC: 1.58 g/l; GC: 1.53 g/l; GG: 1.60 g/l).
The larger differences in hs-CRP levels associated with
IL6 -572G > C agrees with its larger interaction effect.
Lastly, our study had sample size limitations, especially
among the CC genotype carriers of IL6 -572G > C, lim-
iting the statistical power to detect more associations.
Despite this, we made some statistically significant
observations.
Conclusions
Our findings suggest that homozygous carriers of the com-
mon pro-inflammatory major ‘G’ allele of IL6 -572G >C
polymorphism may be more susceptible to the diabeto-
genic effects of particulate matter, supporting the relevance
of inflammatory pathways in the relationship between air
pollution and diabetes. If confirmed, our results are of high
public health relevance considering the ubiquity of the
major G alleles, which put a substantial proportion of the
population at risk for the development of diabetes as a
result of exposure to air pollution. Our results therefore
call for replication by other longitudinal population-based
studies with adequate air pollution, genotype and diabetes
information.
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